BRISBANE, Australia, 18 March 2026 — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today highlights the continued development of the MGI Australia and New Zealand Customer Experience Centre (ANZ CEC) in Brisbane.
Established at the QIMR Berghofer Medical Research Institute in 2021, the facility has evolved from an initial demonstration site into a technology hub aligned with MGI’s global CEC initiative, supporting researchers and applied laboratories across Australia and New Zealand.
Guided by the principle of Empower, Validate and Optimise, the CEC provides a collaborative environment where laboratories can explore leading sequencing, automation and multi-omics technologies before implementing them within their own organisations.
Bridging Global Innovation and Local Needs
The CEC connects MGI’s global technology development with the practical needs of laboratories across Australia and New Zealand.
Built on a user-first approach, the centre enables researchers and laboratories to explore new technologies while maintaining full ownership of their data, workflows and downstream applications.
Activities at the CEC include:
- Empower: providing hands-on access to advanced multi-omics platforms for discovery science and emerging applications.
- Validate: supporting clinical and applied laboratories in evaluating system performance, scalability and workflow integration before in-house implementation.
- Optimise: collaborating with local users to refine workflows across diverse applications ranging from biomedical research, clinical and pathology laboratories, agriculture and environmental science.
The CEC is designed as a collaborative technology empowerment hub, supporting laboratories in exploring and validating workflows before deployment in their own facilities.
An Integrated Technology Portfolio
The CEC continues to showcase MGI’s most advanced technology portfolio across three streams:
- SEQ-ALL: Leading short and long-read sequencing platforms including DNBSEQ and CycloneSEQ, enabling laboratories to generate high-throughput genomic data and scale workflows across research and applied applications.
- Generative Lab Intelligence (GLI): AI-powered laboratory automation platforms to streamline processes from sample preparation through sequencing and data analysis, reducing manual intervention, improving consistency, and increasing laboratory efficiency across high-throughput environments.
- Multi-Omics: A broad portfolio spanning cell omics, spatial omics, spatial proteomics and precision imaging, including DNBelab, Stereo-seq, FluoXpert and Go Optical, helping users explore integrated workflows from single-cell analysis to spatial transcriptomics, proteomics and high-resolution tissue imaging.
A Proven Partner in the ANZ Ecosystem
“Since establishing our presence in Brisbane in 2021, our focus has been on empowering the local ecosystem rather than just showcasing new hardware,” said Dr. Bicheng Yang, Director of MGI Australia and New Zealand. “This multi-omics technology hub is where science and technology come together. Here we support local users in exploring new platforms, optimising workflows and translating innovation into real-world outcomes in research and health.”
The centre welcomes researchers, core facilities, and industrial users to experience this technology hub first-hand through personalized visits and technical collaborations.
To learn more or schedule a tour, visit the CEC webpage here.
